HPQ Silicon Valuation
Is O08 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of O08 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate O08's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate O08's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for O08?
Key metric: As O08 is unprofitable and pre-revenue we use its Price-To-Book Ratio for relative valuation analysis.
| What is O08's PB Ratio? | |
|---|---|
| PB Ratio | -91.3x |
| Book | -CA$1.03m |
| Market Cap | CA$96.04m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | n/a |
| Enterprise Value/EBITDA | -19.5x |
| PEG Ratio | n/a |
Price to Book Ratio vs Peers
How does O08's PB Ratio compare to its peers?
| Company | Forward PB | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 1.6x | ||
BNN BRAIN Biotech | 4.2x | 71.5% | €70.6m |
NTG Nabaltec | 0.8x | 5.8% | €122.8m |
2HRA H&R GmbH KGaA | 0.3x | 34.4% | €127.3m |
UZU Uzin Utz | 0.9x | 2.1% | €244.1m |
O08 HPQ Silicon | n/a | n/a | €96.0m |
Price-To-Book vs Peers: O08 has negative equity and a Price-To-Book Ratio (-91.3x) compared to the peer average (1.6x).
Price to Book Ratio vs Industry
How does O08's PB Ratio compare vs other companies in the DE Chemicals Industry?
Price-To-Book vs Industry: O08 has negative equity and a Price-To-Book Ratio (-91.3x) compared to the European Chemicals industry average (1.4x).
Price to Book Ratio vs Fair Ratio
What is O08's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PB Ratio | -91.3x |
| Fair PB Ratio | n/a |
Price-To-Book vs Fair Ratio: Insufficient data to calculate O08's Price-To-Book Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Central Asia Metals
UK£276.3m
Operates as a base metals producer.
9C3
UK£1.88
7D
1.1%
1Y
-3.6%
Compañía de Minas BuenaventuraA
US$3.1b
Engages in the exploration, development, construction, and operation of mineral processing business.
MBU
US$11.40
7D
-0.9%
1Y
37.3%
Ecora Resources
UK£159.3m
Operates as a natural resource royalty and streaming company in Australia, North and South America, Europe, and internationally.
HGR
UK£0.77
7D
7.7%
1Y
-26.9%